Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Mondae
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict70/ 100
Grade C · #154Mondae
Priced before the intake, and billed every 28 days behind a homepage that quotes the prepay rate.
Visit MondaeThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 70/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Mondae still earns its place — a price-led shopper who counts thirteen charges a year rather than twelve.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results74
92
Real-world results74
97Price honesty68
97
Price honesty68
96Prescriber access66
96
Prescriber access66
88Formulary choice74
88
Formulary choice74
95Cancellation fairness70
95
Cancellation fairness70
93Member support66
93
Member support66
Price, coverage & features
| Metric | CoreAge Rx | Mondae |
|---|---|---|
| Verdict Score | 94/100 | 70/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $87/mo (billed every 28 days, compounded) |
| Tirzepatide | $149/mo | $126/mo (billed every 28 days, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Mondae
What we like
- Both molecules are priced openly on the product pages before any intake rather than behind a questionnaire
- The intake states the billing cycle outright — shipped and billed every 28 days — rather than leaving the reader to infer it
- Support hours are published as a real window, and the checkout prints the next renewal date and amount before you commit
- A three-month prepay is offered as an option rather than as the only way to reach the advertised price
- Financing options are disclosed on the longer plans, and the patient portal handles cancellation
The caveats
- The homepage floors are three-month prepay rates, and the hero figure sits above a grid whose lowest number is lower still
- Per month means 28 days here, so a year is thirteen charges rather than twelve, and only the intake says so
- The prepay plan is one charge covering twelve weeks, and the Terms say fees are not refundable in whole or in part once medication has shipped
- No phone number exists anywhere on the domain, so a billing dispute is an email thread
- The GLP-1 pages name no pharmacy at all — the one pharmacy named on the site is attached only to the peptide products — and no clinician, medical group or NPI is published
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
A price-led shopper who counts thirteen charges a year rather than twelve.
Visit Mondae Read the full Mondae review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Mondae does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.